Catheter ablation improves outcomes in patients with AF and end-stage HF

Nature Reviews Cardiology, Published online: 11 September 2023; doi:10.1038/s41569-023-00932-9In the CASTLE HTx trial, patients with symptomatic atrial fibrillation and end-stage heart failure who underwent catheter ablation and received medical therapy had improved outcomes compared with patients who received medical therapy only.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Source Type: research